COVID-19 Research

Please note the following Covid-19 udpates:

The NIH has a New COVID-19 Research Website and has discussed it in the Extramural Nexus .

Note the Columbia University [Covid-19] Test and Trace Program Spring 2021 Plan.  Make an Appointment

We’ve posted the content of our Restarting Research Town Hall 09/11/2020 [Archival], and also note: the CUIMC Getting Back to Research: IRB Considerations Survey, the Guidelines and Downloadable Form [For Resumption of Field Research (International Studies)], and Appointment for Covid-19 Testing  [Please note the New Phone Number 212-854-7426] links.

Pivot has updated its Dashboard! Here's a Pivot Quick Guide, and you may access the Pivot Overview-Find Funding and Collaborators-Webinar 02.17.2021 Slides

SPA COVID TOWN HALLS [ARCHIVAL] [Please note the New Phone Number for Covid-19 testing, 212-854-7426].

Mailman School; Returning to Campus

NIH has updated its Funding Opportunities Specific to COVID-19 Webpage

CU RESEARCH SPA's COVID-19 Funding Opportunities Webpage

The NIH has created an COVID-19 Literature: The COVID-19 Portfolio Tool

Dedicated CU Website COVID-19: FAQs and Resources Relating to Research

Coronavirus Funding Opportunities Curated by SPA in PIVOT [this link may require Pivot Registration to access]

Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients

Research Resources has curated the following list of announcements and funding opportunities for COVID-19 research

Covid-19 focused opportunities and announcements, R2eport Archival New This Week (NTW) Tabular 07/31/2020 – 12/20/2019
Category (first appearance)	Title (linked)	Sponsor	Deadline (if multiple, first and last presented)
COVID 19 NIH ANNOUNCEMENTS	NIH COVID-19 Funding and Funding Opportunities NIH Extramural Nexus	NIH	04/13/2020 (Release Date)
COVID-19	Flexibilities Available to AHRQ Recipients and Applicants Directly Impacted by the Novel Coronavirus (COVID-19) Due to Loss of Operations	Agency for Healthcare Research and Quality (AHRQ)	NA
COVID-19	HICCC; UPDATE ON NIH FUNDING FOR COVID RESEARCH	Columbia University Herbert Irving Comprehensive Cancer Center; https://cancer.columbia.edu/	NA, please see individual funding opportunities
COVID-19	NICHD Late Application Policy for Institutional Training Grants to RFA-HD-21-014 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)	Eunice Kennedy Shriver National Institute of Child Health and Human Development	NICHD understands that the emergency declaration related to Coronavirus Disease 2019 (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner.; Training grant applications submitted to the Request for Applications RFA-HD-21-014 with a due date of May 27, 2020 will be accepted as late applications through 5 PM local time June 30, 2020.; Institutions need not request advance permission to submit late due to this declared emergency and a cover letter referencing this Notice may be submitted but is not required.; Please note that we anticipate, but cannot guarantee, that all late applications submitted by June 30, 2020 will be reviewed in the council round to which they were submitted (e.g. January 2021); 06/30/2020
COVID-19	Notice of NICHD Participation in NOT-EB-20-012 "Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)"	Eunice Kennedy Shriver National Institute of Child Health and Human Development	It is anticipated that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner. Hence, the May 28, 2020 due date for Funding Opportunity Announcement PAR-19-215 has been changed to June 29, 2020 by 5:00 PM local time of applicant organization.; 06/29/2020 (New Due Date)
COVID-19	NICHD Late Application Policy for Institutional Training Grants to RFA-HD-21-014 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)	Eunice Kennedy Shriver National Institute of Child Health and Human Development	NICHD understands that the emergency declaration related to Coronavirus Disease 2019 (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner.; Training grant applications submitted to the Request for Applications RFA-HD-21-014 with a due date of May 27, 2020 will be accepted as late applications through 5 PM local time June 30, 2020.; Institutions need not request advance permission to submit late due to this declared emergency and a cover letter referencing this Notice may be submitted but is not required.; Please note that we anticipate, but cannot guarantee, that all late applications submitted by June 30, 2020 will be reviewed in the council round to which they were submitted (e.g. January 2021); 06/30/2020
COVID-19	Notice of NICHD Participation in NOT-EB-20-012 "Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)"	Eunice Kennedy Shriver National Institute of Child Health and Human Development	It is anticipated that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner. Hence, the May 28, 2020 due date for Funding Opportunity Announcement PAR-19-215 has been changed to June 29, 2020 by 5:00 PM local time of applicant organization.; 06/29/2020 (New Due Date)
COVID-19	NICHD Late Application Policy for Institutional Training Grants to RFA-HD-21-014 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)	Eunice Kennedy Shriver National Institute of Child Health and Human Development	NICHD understands that the emergency declaration related to Coronavirus Disease 2019 (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner.; Training grant applications submitted to the Request for Applications RFA-HD-21-014 with a due date of May 27, 2020 will be accepted as late applications through 5 PM local time June 30, 2020.; Institutions need not request advance permission to submit late due to this declared emergency and a cover letter referencing this Notice may be submitted but is not required.; Please note that we anticipate, but cannot guarantee, that all late applications submitted by June 30, 2020 will be reviewed in the council round to which they were submitted (e.g. January 2021); 06/30/2020
COVID-19	Notice of NICHD Participation in NOT-EB-20-012 "Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)"	Eunice Kennedy Shriver National Institute of Child Health and Human Development	It is anticipated that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner. Hence, the May 28, 2020 due date for Funding Opportunity Announcement PAR-19-215 has been changed to June 29, 2020 by 5:00 PM local time of applicant organization.; 06/29/2020 (New Due Date)
COVID-19 FOUNDATION FUNDING MATERNAL AND CHILD HEALTH	Ferring COVID-19 Investigational Grants	Ferring Pharmaceuticals	Ferring COVID-19 Investigational Grants will be awarded within 14 days of receipt from 15^th April – 31^st October 2020.; 10/31/2020
COVID-19 FOUNDATION FUNDING	COVID-19 Early Treatment Fund (CETF)-Outpatient clinical trials for COVID-19	http://www.treatearly.org/	Open
COVID-19 HIGH PERFORMANCE COMPUTING	SRCPAC Major players offering Access to High Performance Computing for COVID-19 Research [1] Covid-19 High Performance Computing HPC Consortium [2] Covid-19 HPC High Performance Computing Webinar Presentation [3] All Active Projects, Covid-19 HPC High Performance Computing Consortium [4] Proposal Submission Website, Covid-19 HPC High Performance Computing Consortium	https://covid19-hpc-consortium.org/; [Covid-19 High Performance Computing HPC Consortium]	Please see all active projects
COVID-19	COVID-19 (Novel Coronavirus): Frequently Asked Questions Relating to Research	https://research.columbia.edu	NA; This webpage will continue to be updated frequently as new information is received.
COVID-19 BIG DATA	Columbia Researchers Against COVID-19 (The CRAC Team)	https://www.olivelab.org	Ongoing
COVID-19	Columbia University Biobank	https://www.ps.columbia.edu/research/core-and-shared-facilities/core-facilities-category	NA
COVID-19 WITHDRAWN DUE TO COVID-19 PANDEMIC	WITHDRAWN at this point due to Covid-19 pandemic; V Foundation Translational Cancer Research Grant Program	https://www.v.org/research/	Due to the Covid-19 pandemic, the 2020 Translational grant (adult cancer types) Request For Applications (RFA), has been withdrawn, effective immediately
COVID-19 WEEKLY HIGHLIGHT RETURNING TO CAMPUS	[1] Mailman School; Returning to Campus [2] Mailman School; Returning to Campus update 07/22/2020 [3] Mailman School; Returning to Campus update 07/30/2020 [4] Mailman School; Returning to Campus; Survey re MSPH IRB Approved Project Resumption, please complete by COB 08/02/2020 [5] Mailman School; Returning to Campus; IRB Focused Town Hall 07/29/2020 Archived AV	Mailman School	NA; page updated regularly
COVID-19 LATE APPLICATION POLICY	Late Application Policy for May 25, 2020, Application Due Date of NCI's Cancer Research Education Grants Program (R25) Funding Opportunity Announcements PAR-18-476, PAR-18-477, and PAR-18-478 Due to Public Health Emergency for US Coronavirus Disease 2019	National Cancer Institute	Cancer research education (R25) grant applications submitted to NCI's Funding Opportunity Announcements PAR-18-476, PAR-18-477, and PAR-18-478 for the application due date of May 25, 2020, will be accepted for consideration if complete and received by 5:00 PM local time June 30, 2020
COVID-19	Notice of NCATS' Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"	National Center for Advancing Translational Sciences	See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; ; 03/10/2023 (Expiration)
COVID-19	Notice of NCATS' Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"	National Center for Advancing Translational Sciences (NCATS)	Earliest start dates may vary by awarding IC. See the Urgent Guide Notices for any applicable Application Due Dates. ; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; 01/25/2022 (Expiration, PA-18-935)
COVID-19	Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) NOT-AT-20-011	National Center for Complementary and Integrative Health; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism	Due dates may vary by awarding IC. See the awarding IC's web site for any applicable Application Due Dates
COVID-19	NHLBI Announces Availability of Frequently Asked Questions (FAQs) for NOT-HL-20-757, Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)	National Heart, Lung, and Blood Institute	NA
COVID-19	Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)	National Institute of Allergy and Infectious Diseases	Applications will be accepted on a rolling basis, beginning on 04/30/2020; 04/30/2021 (Expiration)
COVID-19	Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)	National Institute of Allergy and Infectious Diseases	Applications will be accepted on a rolling basis, beginning on 04/30/2020; 04/30/2021 (Expiration)
COVID-19 LATE APPLICATION POLICY	NIAID Late Application Policy for NIAID-Specific RFAs with Due Dates in June 2020	National Institute of Allergy and Infectious Diseases	[1] Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed) RFA-AI-20-019 ; 06/15/2020 (Application Deadline); 06/29/2020 (Late applications accepted until this date) ; [2] Childhood Asthma in Urban Settings -Clinical Research Centers (U01 Clinical Trial Optional) RFA-AI-19-073; 06/19/2020 (Application Deadline); 07/06/2020 (Late applications accepted until this date); [3] Childhood Asthma in Urban Settings Clinical Research Network- Leadership Center (UM1 Clinical Trial Required); RFA-AI-19-074; 06/19/2020 (Application Deadline); 07/06/2020 (Late applications accepted until this date); [4] Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed); RFA-AI-20-028 06/29/2020 (Application Deadline); 07/13/2020 (Late applications accepted until this date)
COVID-19	Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)	National Institute of Allergy and Infectious Diseases	Applications for this limited competition FOA will be accepted on a rolling basis, beginning 07/13/2020; 07/08/2021 (Expiration)
COVID-19	Notice of Expiration of PAR-20-178 "Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)"	National Institute of Allergy and Infectious Diseases	Applications will be accepted on a rolling basis, beginning on 04/30/2020; 08/14/2020 (Revised Expiration Date); After this date, applicants are encouraged to consider applying to PA-19-056, NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
COVID-19	Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)	National Institute of Allergy and Infectious Diseases	Applications for this limited competition FOA will be accepted on a rolling basis, beginning 07/13/2020; 07/08/2021 (Expiration)
COVID-19	Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)	National Institute of Biomedical Imaging and Bioengineering	It is anticipated that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner. Hence, the May 28, 2020 due date for Funding Opportunity Announcement PAR-19-215 has been changed to June 29, 2020 by 5:00 PM local time of applicant organization.; 07/29/2020 (Extended Deadline); 05/29/2021 (Expiration)
COVID-19	Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR	National Institute of Dental and Craniofacial Research; Office of Research on Women's Health	Please see piecemeal related announcements
COVID-19	Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)"	National Institute of Environmental Health Sciences	NA
COVID-19	Guidance for Cost-Related Flexibilities Available to Support of Competitive Research (SCORE) Award Recipients Affected by COVID-19	National Institute of General Medical Sciences	NA, please see Guidance
COVID-19 EMERGENCY COMPETITIVE REVISION TO EXISTING NIH AWARDS	Notice of NIMH Participation in PA-20-135, "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"	National Institute of Mental Health	See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; 03/10/2023 (Expiration) [For PA-20-135]
COVID-19 K-AWARDS	Notice to Extend Eligibility for Submission of Diversity K22 Applications due to COVID related Disruptions	National Institute of Neurological Disorders and Stroke	NINDS understands that COVID-19 has caused a major disruption in the ability of many individuals to make progress on their research. Though subject to future updates, NINDS now will provide at least a 2-receipt cycle extension (roughly 8 additional months) of eligibility for individuals whose eligibility to apply for the K22, under normal eligibility rules (including resubmission policy as defined in NOT-OD-18-197), is expiring between June/July 2020 and February/March 2021 (inclusive of these dates). In addition, those who normally would have been eligible to apply for the June/July 2021 receipt date will have a 1-receipt cycle (roughly 4 months) extension
COVID-19 EMERGENCY COMPETITIVE REVISION TO EXISTING NIH AWARDS	Notice of Participation of National Institute of Nursing Research (NINR) in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional")	National Institute of Nursing Research	See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; 03/10/2023 (Expiration) [For PA-20-135]
COVID-19	Notice of NIA Participation in PA-20-135, "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"	National Institute on Aging	See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; 03/10/2023 (Expiration) [PA-20-135]
COVID-19	Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19	National Institute on Deafness and Other Communication Disorders	Please see deadlines for piecemeal Supplements, this Notice does not affect their due dates
COVID-19 EMERGENCY COMPETITIVE REVISION TO EXISTING NIH AWARDS	Notice of NLM's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"	National Library of Medicine	See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; 03/10/2023 (Expiration) [For PA-20-135]
COVID-19 NSF	National Science Foundation awards rapid response grants to support coronavirus (COVID-19) research NSF COVID-19 RAPID Awards National Science Foundation Dear Colleague Letter	National Science Foundation	Please see piecemeal / individual opportunities
COVID-19	[1] NIH Rapid Acceleration of Diagnostics (RADx) Program [2] Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations [3] Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations [4] Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations [5] Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) [6] Announcements of NIEHS Grant Opportunities	NIH	please see piecemeal opportunities which are also listed separately in this week’s Newsletter
COVID-19	OBSSRS Updates; COVID-19 Urgent Competitive Revisions and Administrative Supplement Notices of Scientific Interest (NOSIs) Relevant to the Social and Behavioral Sciences	NIH Office of Behavioral and Social Sciences Research	See piecemeal OBSSR_Relevant NOSIs
COVID-19 T32S LATE APPLICATION POLICY	Parent T32 applications - accepting late applications; NIH Late Application Policy for Institutional Training Grants to PA-20-142 and PA-20-162 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)	Office of The Director, National Institutes of Health (OD)	Training grant applications submitted to the Parent Funding Opportunity Announcements PA-20-142 and PA-20-162 with a due date of May 25 will be accepted through June 30, 2020.; Please note that we anticipate, [SPA Caveat] we cannot guarantee, that all late applications submitted by June 30, 2020 will be reviewed in the council round to which they were submitted (e.g. January 2021).
COVID-19 FOUNDATION FUNDING	Pfizer Global Medical Grants program: New Research RFP in COVID-19	Pfizer	To facilitate a rapid response, application reviews and approvals will be done on a rolling basis. Although the RFP application window is open for 4 weeks, organizations are encouraged to apply as soon as possible. We anticipate a high volume of applications and will continue to award grants until the budget is depleted, in which case the RFP will close before the listed closing date; 05/20/2020 (RFP Start Date); 06/17/2020 (Application closing date)
COVID-19 FOUNDATION FUNDING	Systems for Action: Supplemental Research on COVID-19 Response and Recovery 07/06/2020 (Webinar); 08/05/2020 (Application)	Robert Wood Johnson Foundation
COVID-19 NSF	[1] NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) [2] NSF Supporting Research to Address Coronavirus Disease	NSF	03/04/2020 (Release Date)
COVID-19 COMMENTARY RWJF	COVID-19 Commentary; RWJF President; Washington Post; As coronavirus spreads, the bill for our public health failures is due	Commentary, RWJF President, Washington Post	Published 03/05/2020
COVID-19 NIH ANNOUNCEMENTS	General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19	NIH; Office of The Director, National Institutes of Health (OD)	03/10/2020 (Release Date)
COVID-19 COGR	Council on Governmental Relations (COGR); Frequently Asked Questions Regarding COVID-19’s Impact on Federal Awards	COGR; https://www.cogr.edu/	NA, 03/12/2020 (update, Release Date)
COVID-19	Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19	National Institutes of Health	03/16/2020 (Release Date)
COVID-19	Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19	National Institutes of Health; Office of The Director, National Institutes of Health (OD)	03/16/2020 (Release Date)
COVID-19 NIH ANNOUNCEMENTS	Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients	NIH	NA 03/17/2020 (Last updated)
COVID-19	Archived Research Resources Covid-19 Transmission to Faculty 03/18/2020	Research Resources	03/18/2020 (Transmission Date)
COVID-19 OMB MEMORANDUM	Memorandum to the Heads of Executive Departments and Agencies; 03/19/2020; Executive Office of the President Office of Management and Budget	Executive Office of the President Office of Management and Budget	03/19/2020 (Release Date)
COVID-19	R2eport 03/20/2020 Newsletter Preamble; A Message from The Vice Dean for Research Strategy and Innovation	Research Resources	R2eport 03/20/2020 Newsletter Preamble
COVID-19	A Message from the Vice Dean for Research Strategy And Innovation	Research Resources	03/20/2020 (Release Date)
COVID-19	Research Resources Covid-19 Transmission to Faculty 03.23.2020 Archived	Research Resource	03/23/2020 (Transmission Date)
COVID-19 CDC BAA	The Centers for Disease Control and Prevention (CDC) has issued a Broad Agency Announcement (BAA) for research proposals related to Covid-19 CDC BAA for Research Proposals related to Covid-19, Full Announcement	CDC	03/25/2020
COVID-19 NSF SMALL BUSINESS	NSF Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19	NSF; https://www.nsf.gov	03/25/2020 (Release Date); please see piecemeal opportunities
COVID-19	Notice of Intent: Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Address Health System Responsiveness to COVID-19	Agency for Healthcare Research and Quality http://www.ahrq.gov	03/26/2020 (Release Date)
COVID-19	Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19	Agency for Healthcare Research and Quality; http://www.ahrq.gov	03/26/2020 (Release Date)
COVID-19	FDA - Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19	Food and Drug Administration	03/26/2020 (Release Date)
COVID-19 NIH LATE APPLICATION POLICY AND ACCOMPANYING VIDEO	NIH Update: Responding to Frequent Questions on Flexibilities Related to NIH Funding and COVID-19 [1] Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients [2] Update: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) [3] Update on Covid-19 Flexibilities for the Research Community; Mike Lauer, NIH Deputy Director for Extramural Research; Video	NIH; Office of Extramural Research	03/26/2020 (Release Date) ; Please read the notice in its entirety. Grant applications submitted late for due dates between March 9, 2020, and May 1, 2020, will be accepted through May 1, 2020
COVID-19 SPA	COVID-19 FAQ Updates and Pay Continuation on Sponsored Projects We are currently assessing a number of recently released sponsor FAQs. We will be updating a number of FAQs on our website shortly. Recently released sponsor FAQs include: [] Department of Energy [] National Institutes of Health [*] See new Late Application Policy [] National Science Foundation [*] See Impact on Existing NSF Grant Deadlines [] Department of Defense [] USAMRAA COVID-19 Resources [] Defense Advanced Research Projects Agency Please continue to email questions to COVID19_research@columbia.edu; we will make sure your questions are routed to the right person so you receive a timely answer. Thank you. Sincerely, The Offices of the Executive Vice President for Research	SPA	NA, 03/27/2020 (Release Day)
COVID-19 SPA	COVID-19 FAQ Updates and Pay Continuation on Sponsored Projects	SPA	NA, 03/27/2020 (Release Day)
COVID-19 COLUMBIA UNIVERSITY BIOBANK UPDATE	[1] Columbia University Biobank Update [2] Columbia University Biobank	https://www.ps.columbia.edu/research/core-and-shared-facilities/core-facilities-category	NA; The Columbia University Biobank (CUB) launched in April 2020 to advance our understanding of COVID-19 and its devastating clinical consequences has issued a CUB Update [06.17.2020] and encourages you to apply to use these research resources through the CUB website
COVID-19 SPA ANNOUNCEMENT: COVID-19 FUNDING OPPORTUNITIES AND NEW WEBSITE	Resources to get Covid Funding Opportunities: COVID-19 Funding Opportunities and New Website [1] COVID-19: FAQs and Resources Relating to Research [Columbia Research and SPA] [2] COVID-19 Research Opportunities and other resources to support researchers [3] Pivot a Funding Opportunity Database, as a one-stop shop to identify COVID-19 opportunities from federal, private, and global sponsors [4] Pivot Instructions [5] Coronavirus Funding Opportunities Curated by SPA in PIVOT	Columbia Research/SPA	NA, Distributed 04/03/2020
COVID-19 AMERICAN HEART ASSOCIATION	American Heart Association Covid-19 Research Grants	https://heart.org	04/06/2020
COVID-19 NIH NOTICES	COVID-19 research: Notice of Early Expiration of NOT-AI-20-030; Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)," NOT-AI-20-030	National Institute of Allergy and Infectious Diseases (NIAID); National Institute of General Medical Sciences (NIGMS)	NOT-AI-20-030 is going to expire as of 4/8/2020
COVID-19	University Life Forum: Your Questions Answered on COVID-19 this Monday, April 13 (04.13.2020) at 12:15 pm on Zoom	CU University Life	04/13/2020 (Event Date)
COVID-19 NIH ANNOUNCEMENTS	NIH COVID-19 Funding and Funding Opportunities NIH Extramural Nexus	NIH	04/13/2020 (Release Date)
COVID-19 NIH EXTRAMURAL NEXUS	NIH Extramural Nexus New NIH Resource to Analyze COVID-19 Literature: The COVID-19 Portfolio Tool	NIH Office of Extramural Research; https://grants.nih.gov/grants/oer.htm	04/15/2020 (Release Date)
COVID-19 PILOT	[1] The Herbert Irving Comprehensive Cancer Center (HICCC) is seeking applications for research projects focused on SARS-CoV-2 (COVID-19) [2] HICCC COVID-19 RFA	HICCC	04/17/2020
COVID-19 NIH EXTRAMURAL NEXUS	[1] NIH Extramural Nexus; Temporary, Emergency Situations Due to COVID-19 and Application Scores Received During Peer Review [2] NIH Coronavirus Update Guidance for Peer Reviewers [3] Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding	NIH Office of Extramural Research; https://grants.nih.gov/grants/oer.htm	04/21/2020 (Release Date)
COVID-19	NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)	National Institute of Environmental Health Sciences	04/24/2020 (First Available Due Date); 04/25/2020
COVID-19	Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)	National Institute of Environmental Health Sciences	04/24/2020 (Frist Available Due Date); 04/25/2020 (Expiration)
COVID-19	Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis	National Cancer Institute	04/28/2020 (Release Date); For the duration of the present crisis
COVID-19	Translational Therapeutics(TRx) Accelerator Request for Proposal COVID-19 THERAPEUTICS Irving Institute for Clinical and Translational Research Herbert Irving Comprehensive Cancer Center Department of Biomedical Engineering 2020	https://www.irvinginstitute.columbia.edu/about-us/resources-and-cores/translational-therapeutics-accelerator-trx	04/30/2020
COVID-19 WEBINAR	Before, During & After Flattening the Curve: Decreasing COVID-19 Transmission in Settings with Limited Health Resources	The Heilbrunn Department of Population and Family Health; Program on Forced Migration and Health (PopFam Dept)	04/30/2020, 9:00 AM – 11:30 AM (Webinar Date and time)
COVID-19 ENVIRONMENTAL	Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) [NOT-ES-20-015]	NIH; NIEHS	05/01/2020 (First Available Due Date); 05/01/2020 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19	National Institute of General Medical Sciences	05/05/2020 (First Available Due Date); 05/06/2020 (Expiration Date)
COVID-19	Columbia-IBM Center for Blockchain and Data Transparency: Special Call for COVID-19 Research	https://cu-ibm-blockchain-data.columbia.edu/	05/08/2020
COVID-19 SPONSORED PROJECTS ADMINISTRATION TOWN HALL	Sponsored Projects Administration Town Hall: A Discussion of COVID-19’s Impact, hosted by SPA, 05/08/2020	SPA	05/08/2020, 10AM – 11AM
COVID-19	NIDCR Announces Availability of Frequently Asked Questions (FAQs) for Coronavirus Disease 2019 (COVID-19)-Related Notices of Special Interest (NOSI) NOT-DE-20-022 and NOT-DE-20-023	National Institute of Dental and Craniofacial Research	05/13/2020 (Release Date)
COVID-19 FOUNDATION FUNDING	TraceLink Covid-19 Grant	www.tracelink.com	05/15/2020
COVID-19	Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus	National Human Genome Research Institute	04/03/2020 (First Available Due Date); 05/16/2020 (Expiration Date)
COVID-19	Notice of Early Expiration of Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)," NOT-AI-20-031	National Institute of Allergy and Infectious Diseases	05/19/2020 (Expiration [Rescinded Date])
COVID-19 AMERICAN DIABETES ASSOCIATION	American Diabetes Association Covid-19 Funding Opportunity	American Diabetes Association	05/22/2020
COVID-19 T32 TRAINING GRANTS	Notices for changes in T32 submission instructions ; Reminder: Changes to Forms and Instructions for Research Training Grant, Fellowship, and Career Development Award Applications for Applications Due on or After May 25, 2020 [NOT-OD-090]	NIH; NIEHS	05/25/2020 (for Research Training Grant, Fellowship, and Career Development Award Applications for Applications Due on or After May 25, 2020); By way of this Notice, the National Institutes of Health and the Agency for Healthcare Research and Quality are reminding the biomedical and health services research communities of changes to forms and instructions for research training grant, fellowship, and career development award applications for due dates on or after May 25, 2020
COVID-19 PCORI	PCORI COVID-19 TARGETED PFA FAQS relative to PCORI COVID-19 TARGETED PFA	https://www.pcori.org	05/26/2020
COVID-19	Request for Information (RFI): Strategy for Research in Coronavirus Serology Testing and Serological Sciences	National Cancer Institute	05/26/2020 (Response Date)
COVID-19	Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)	Agency for Healthcare Research and Quality	05/29/2020; 06/01/2020 (Expiration)
COVID-19	Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)	Agency for Healthcare Research and Quality	04/29/2020; 06/01/2020 (Expiration)
COVID-19	Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)	Agency for Healthcare Research and Quality	05/29/2020; 06/01/2020 (Expiration)
COVID-19	Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK	National Institute of Diabetes and Digestive and Kidney Diseases	06/01/2020 (First Available Due Date); 06/02/2020 (Expiration)
COVID-19	Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission	National Institute of Diabetes and Digestive and Kidney Diseases	06/01/2020 (First Available Due Date); 06/02/2020 (Expiration Date)
COVID-19	Notice of Additional Activity Code Accepted for "NOT-DK-20-018, Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK"	National Institute of Diabetes and Digestive and Kidney Diseases	06/01/2020 (First Available Due Date); 06/02/2020 (Expiration)
COVID-19	Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19)	National Institute on Deafness and Other Communication Disorders	04/07/2020 (First Available Due Date); 06/02/2020 (Expiration)
COVID-19	Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19)	National Library of Medicine	06/01/2020 (First Available Due Date); 06/02/2020 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19)	National Library of Medicine	06/01/2020 (First Available Due Date); 06/02/2020 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)	National Institute of Biomedical Imaging and Bioengineering	06/05/2020 (First Available Due Date); 06/05/2020 (Expiration Date)
COVID-19 BIG DATA	RDA COVID-19 Guidelines and Recommendations	Research Data Alliance, RDA, https:///www.rd-alliance.org	06/08/2020
COVID-19	Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency	National Institutes of Health	06/10/2020 (Release Date, this is a NOI, Notice of Information)
COVID-19	Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01)	Agency for Healthcare Research and Quality	06/15/2020; 06/16/2020 (Expiration)
COVID-19	Pre-Application Webinar for NCI's Serological Sciences Network Funding Opportunities (RFA-CA-20-038, RFA-CA-20-039)	National Cancer Institute; National Institute of Allergy and Infectious Diseases	06/18/2020 (Application Webinar for RFA-CA-20-038 and RFA-CA-20-039)
COVID-19	Notice of Special Interest (NOSI): Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Need for Documenting 2019 Novel Coronavirus Disease (COVID-19)-Related Patient Outcomes	National Institute of General Medical Sciences	06/18/2020 (First Available Due Date); 06/19/2020 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)	Office of Strategic Coordination (Common Fund)	04/15/2020 (First Available Due Date) 06/20/2020 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) related Research	National Institutes of Health	06/22/2020 (First Available Due Date); 06/23/2020 (Expiration Date)
COVID-19 NIH DIRECTORS AWARDS WEBINARS	Notice of Pre-Application Webinars for the High-Risk, High-Reward Research Program's Pioneer, New Innovator, Transformative Research, and Early Independence Awards 06.25.2020 Webinar for NIH Director’s New Innovator Award; Register for the 06.25.2020 Webinar for the NIH Director’s New Innovator Award on WebEx 06.26.2020 Webinar for NIH Director’s Pioneer Award; Register for the 06.26.2020 Webinar for the NIH Director’s Pioneer Award on WebEx 06.29.2020 Webinar for NIH Director’s Early Independence Award; and NIH Director’s Emergency Early Independence Award; Register for the 06.29.2020 Webinar for the NIH Director’s Early Independence Award and the NIH Director’s Emergency Early Independence Award on WebEx 06.29.2020 Webinar for NIH Director’s Transformative Research Award; and NIH Director’s Emergency Transformative Research Award; register for 06.29.2020 Webinar for the NIH Director’s Transformative Research Award and the NIH Director’s Emergency Transformative Research Award on WebEx	Office of Strategic Coordination (Common Fund)	Submit your questions for the 06.25.2020 Webinar for the NIH Director’s New Innovator Award by 11:59 PM local time on Monday, June 22, 2020, to NewInnovatorAwards@mail.nih.gov.; Submit your questions for the 06.26.2020 Webinar for the NIH Director’s Pioneer Award by 11:59 PM local time on Tuesday, June 23, 2020, to PioneerAwards@mail.nih.gov ; Submit your questions for the 06.29.2020 Webinar for the NIH Director’s Early Independence Award and the NIH Director’s Emergency Early Independence Award by 11:59 PM local time on Thursday, June 25, 2020, to EarlyIndependence@od.nih.gov; Submit your questions for the 06.29.2020 Webinar for the NIH Director’s Transformative Research Award and the NIH Director’s Emergency Transformative Research Award by 11:59 PM local time on Thursday, June 25, 2020, to Transformative_Awards@mail.nih.gov
COVID-19	Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)	National Cancer Institute	04/14/2020 (First Available Due Date); 06/26/2020 (Expiration)
COVID-19	Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)	National Cancer Institute	04/14/2020 (First Available Due Date); 06/26/2020 (Expiration)
COVID-19	Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)	National Cancer Institute	04/14/2020 (First Available Due Date); 06/26/2020 (Expiration)
COVID-19	[1] Scientists, Artists, and Science Communicators Invited to Team Up Against COVID-19 [2] Sigma Xi; Covid-19; Learn More	Sigma Xi, the Scientific Research Honor Society; https://www.sigmaxi.org	06/28/2020
COVID-19	Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)	National Institute of Biomedical Imaging and Bioengineering It is anticipated that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner. Hence, the May 28, 2020 due date for Funding Opportunity	Announcement PAR-19-215 has been changed to June 29, 2020 by 5:00 PM local time of applicant organization.; 07/29/2020 (Extended Deadline); 05/29/2021 (Expiration)
COVID-19 LATE APPLICATION POLICY	Late Application Policy for May 25, 2020, Application Due Date of NCI's Cancer Research Education Grants Program (R25) Funding Opportunity Announcements PAR-18-476, PAR-18-477, and PAR-18-478 Due to Public Health Emergency for US Coronavirus Disease 2019	National Cancer Institute	06/30/2020 Cancer research education (R25) grant applications submitted to NCI's Funding Opportunity Announcements PAR-18-476, PAR-18-477, and PAR-18-478 for the application due date of May 25, 2020, will be accepted for consideration if complete and received by 5:00 PM local time June 30, 2020
COVID-19 UNDERSERVED POPULATIONS	Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives	NIH, Office of The Director, National Institutes of Health (OD)	07/2020 (July, 2020; First Estimated Application Due Date)
COVID-19 VICE DEAN’S TOWN HALL	[1] A Message from the Vice Deans of Finance and Administration and Research Strategy and Innovation [2] Mailman School Virtual Town Hall; Resuming Limited On-Site Operations, 06.24.2020	Vice Deans of Finance and Administration and Research Strategy and Innovation	06/24/2020 (Town Hall); 07/01/2020 (Message)
COVID-19	Notice of Correction to NOT-OD-20-119, NOT-OD-20-120, NOT-OD-20-121 Eligibility Section [Added: "Competitive revision applications to this NOSI may not propose new foreign components and may not request additional funding for existing foreign components”]	National Institutes of Health	06/30/2020 (Release Date); 07/08/2020 (First Available Due Date); 09/09/2020 (Expiration) [NOT-OD-20-119, NOT-OD-20-120]; 08/07/2020 (First Available Due Date); 08/08/2020 (Expiration) [NOT-OD-20-121]
COVID-19	[1] NIH Funding Opportunities Specific to COVID-19 Webpage [2] CU RESEARCH SPA COVID-19 Funding Opportunities Webpage	NIH	NA, 07/08/2020 (Release Date)
COVID-19	NIH Funding Opportunities Specific to COVID-19 Webpage CU RESEARCH SPA COVID-19 Funding Opportunities Webpage	NIH	NA, 07/08/2020 (Release Date)
COVID-19 NIH ANNOUNCEMENTS	Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic NIH Review and Award Cycles President's Guidelines for Re-Opening America Again	SPA/NIH	NIH issued guidance today (07/08/2020) related to preparing proposals for the May 2021 Council round beginning with applications submitted for the September 25, 2020 due date (see Review and Award Cycles)
COVID-19 NIH ANNOUNCEMENTS	Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic NIH Review and Award Cycles President's Guidelines for Re-Opening America Again	SPA/NIH	NIH issued guidance today (07/08/2020) related to preparing proposals for the May 2021 Council round beginning with applications submitted for the September 25, 2020 due date (see Review and Award Cycles)
COVID-19 NIH ANNOUNCEMENTS	Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic NIH Review and Award Cycles President's Guidelines for Re-Opening America Again	SPA/NIH	NIH issued guidance today (07/08/2020) related to preparing proposals for the May 2021 Council round beginning with applications submitted for the September 25, 2020 due date (see Review and Award Cycles)
COVID-19 FOUNDATION FUNDING DIVERSITY	CHEST Foundation and American Thoracic Society Research Grant in COVID-19 and Diversity	CHEST Foundation and American Thoracic Society	07/17/2020
COVID-19 FOUNDATION FUNDING	data.org: Inclusive Growth and Recovery Challenge	https://data.org	07/17/2020
COVID-19 FOUNDATION FUNDING	CHEST Foundation Research Grant in COVID-19	https://foundation.chestnet.org	07/17/2020
COVID-19 FOUNDATION FUNDING	Joint European Disruptive: Billion Molecules against Covid-19	Jedi Foundation	07/17/2020
COVID-19	Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional)	National Institute of Mental Health; National Center for Complementary and Integrative Health; National Eye Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Nursing Research; Office of Behavioral and Social Sciences Research; Office of Disease Prevention	07/20/2020 (First Estimated Application Due Date)
COVID-19	[1] Oak Ridge Associated Universities (ORAU)’s University Consortium [2] Surveillance for SARS-CoV-2 Using Wastewater – A leading Edge Indicateor Webinar 07.21.2020 1PM [3] Call for Rapid Access Proposals for Covid-19 Research – Reminder	Oak Ridge Associated Universities (ORAU) University Consortium; https://www.orau.org	07/21/2020 (1PM, Webinar)
COVID-19	Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)	National Institute on Minority Health and Health Disparities; National Center for Complementary and Integrative Health; National Institute on Aging; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Nursing Research; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health	07/22/2020 (First Estimated Due Dates)
COVID-19	Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)	National Cancer Institute; National Institute of Allergy and Infectious Diseases	07/22/2020; 07/23/2020 (Expiration)
COVID-19	Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)	National Cancer Institute; National Institute of Allergy and Infectious Diseases	07/22/2020; 07/23/2020 (Expiration)
COVID-19	[1] RFA-CA-20-039 - Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) [2] Serological Sciences Network for COVID-19 (SeroNet)	National Institutes of Health (NIH); Components of Participating Organizations: National Cancer Institute (NCI); National Institute of Allergy and Infectious Diseases (NIAID)	07/22/2020 (Application); 07/23/2020 (Expiration)
COVID-19 FOUNDATION FUNDING	Chan Zuckerberg Initiative: Imaging Scientists RFA	https://chanzuckerberg.com	07/31/2020
COVID-19 FOUNDATION FUNDING	Gilead Sciences COVID-19 RFP Program: COMMIT	https://www.gilead.com	08/03/2020
COVID-19 LIMITED SUBMISSION	[1A] NIH Director’s Emergency Early Independence Awards – RFA-RM-20-021(for COVID-19 researchers) [Limited Submission, requires CU Uni Login] [1B] RFA-RM-20-021 NIH Link Provided for Reference, this is a Limited Submission Initiative [2A] NIH Director’s Early Independence Awards – RFA-RM-20-014 [Limited Submission, requires CU Uni Login] [2B] RFA-RM-20-014 NIH Link Provided for Reference, this is a Limited Submission Initiative	NIH; Office of Strategic Coordination (Common Fund)	07/09/2020 (Internal, Limited Submission Deadline); 08/04/2020 (NIH Letter of Intent Deadline); 09/04/2020 (NIH Proposal Deadline)
COVID-19 FOUNDATION FUNDING	Russel Sage Foundation: Research on the Covid-19 pandemic and the resulting recession in the U.S.	https://russelsage.org	08/05/2020
COVID-19 FOUNDATION FUNDING	Systems for Action: Supplemental Research on COVID-19 Response and Recovery	Robert Wood Johnson Foundation	07/06/2020 (Webinar); 08/05/2020 (Application)
COVID-19 CANCER K-AWARDS	Notice of Change: Late Application Policy for June 17, 2020, Application Due Date of PAR-19-242, Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Due to Public Health Emergency for US Coronavirus Disease 2019	National Cancer Institute	Late applications will be accepted through 5:00 PM local time July 1, 2020, for PAR-19-242 "Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)" No late applications submitted after July 1, 2020, will be considered.; 07/01/2020 (Late Application Deadline); 06/18/2021 (Expiration)
COVID-19 CANCER K-AWARDS	Notice of Change: Late Application Policy for June 17, 2020, Application Due Date of PAR-19-242, Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Due to Public Health Emergency for US Coronavirus Disease 2019	National Cancer Institute	Late applications will be accepted through 5:00 PM local time July 1, 2020, for PAR-19-242 "Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)" No late applications submitted after July 1, 2020, will be considered.; 07/01/2020 (Late Application Deadline); 06/18/2021 (Expiration)
COVID-19 LATE APPLICATION POLICY	NIA Late Application Policy for NIA-Specific FOAs with Application Due Dates in May, June, and July 2020	National Institute on Aging	Late applications will be accepted by 5:00 PM local time up to two weeks after the application due date for the NIA-specific FOAs listed below. Institutions do not need to request advance permission. While a cover letter may be provided, it is not required to take advantage of this flexibility; please see announcement NOT-AG-20-033
COVID-19	Notice of Corrections to RFA-OD-20-013 "Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)" Budget and Review	National Institutes of Health	08/07/2020; 08/08/2020 (Expiration) [for RFA-OD-20-013]
COVID-19	Emergency Awards: RADx-UP Coordination and Data Collection Center (U24 Clinical Trial Optional)	National Institutes of Health (NIH)	08/07/2020; 08/08/2020 (Expiration)
COVID-19 BIG DATA	Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)	National Institutes of Health; John E. Fogarty International Center; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Cancer Institute; National Eye Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Biomedical Imaging and Bioengineering; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institute of Mental Health; National Institute on Minority Health and Health Disparities; National Institute of Nursing Research; National Library of Medicine; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health	08/07/2020; 08/08/2020 (Expiration)
COVID-19	Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	National Institutes of Health; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Cancer Institute; National Eye Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institute of Mental Health; National Institute on Minority Health and Health Disparities; National Institute of Neurological Disorders and Stroke; National Institute of Nursing Research; National Library of Medicine; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health	08/07/2020 (First Available Due Date); 08/08/2020 (Expiration Date)
COVID-19 LIMITED COMPETITION	Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	NIH	08/07/2020 (First Available Due Date); 08/08/2020 (Expiration)
COVID-19 LIMITED SUBMISSION	Limited Submission; TD Ready Challenge; Internal Deadline 07/08/2020 [Limited Submission Opportunity; Sponsor Link Provided for Reference]		07/08/2020 (Internal Deadline); 08/13/2020 (Sponsor Deadline); Combine both parts of the internal proposal in a single pdf file and email to limitedsubmissions@columbia.edu.; Program Guidelines: https://www.td.com/ca/en/about-td/ready-commitment/funding/the-ready-challenge/; Questions should be sent to Greg Culler at limitedsubmissions@columbia.edu
COVID-19 FOUNDATION FUNDING	Technology Innovations for Urban Living in the Face of COVID-19; Achieving the Vision— Seed Grant RFPl ; Deadline: 08/14/2020	Anonymous Donor via Columbia Engineering	08/14/2020
COVID-19	Notice of Expiration of PAR-20-177 "Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)"	National Institute of Allergy and Infectious Diseases	08/14/2020 (Expiration of PAR-20-177); please consider PA-20-195
COVID-19 CANCER	Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19)	National Cancer Institute (NCI)	07/06/2020 (First Available Due Date); 08/15/2020 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19)	National Center for Complementary and Integrative Health (NCCIH); Office of Research on Women’s Health ( ORWH )	05/22/2020 (First Available Due Date); 08/18/2020 (Expiration Date)
COVID-19 FOUNDATION FUNDING	Merck KGaA: Research grants for technological solutions towards pandemic preparedness	Merck, emd group; https://www.emdgroup.com	08/31/2020
COVID-19 NIH DIRECTOR’S AWARDS PROGRAM	NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional)	Office of Strategic Coordination (Common Fund)	09/04/2020; 09/05/2020 (Expiration)
COVID-19	Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	: NIH; Office of The Director, National Institutes of Health (OD)	07/08/2020 (First Available Due Date); 09/09/2020 (Expiration)
COVID-19	Notice of Correction to NOT-OD-20-120 Eligibility Section for Budget Request Information	National Institutes of Health	07/08/2020 (First Available Due Date); 09/09/2020 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	National Institutes of Health; John E. Fogarty International Center; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Cancer Institute; National Eye Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Biomedical Imaging and Bioengineering; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institute of Mental Health; National Institute on Minority Health and Health Disparities; National Institute of Neurological Disorders and Stroke; National Institute of Nursing Research; National Library of Medicine; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health	07/08/2020 (First Available Due Date); 09/09/2020 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	National Institutes of Health; John E. Fogarty International Center; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Cancer Institute; National Eye Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Biomedical Imaging and Bioengineering; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institute of Mental Health; National Institute on Minority Health and Health Disparities; National Institute of Neurological Disorders and Stroke; National Institute of Nursing Research; National Library of Medicine; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health	07/08/2020 (First Available Due Date); 09/09/2020 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	National Institutes of Health; John E. Fogarty International Center; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Cancer Institute; National Eye Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Biomedical Imaging and Bioengineering; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institute of Mental Health; National Institute on Minority Health and Health Disparities; National Institute of Neurological Disorders and Stroke; National Institute of Nursing Research; National Library of Medicine; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health	07/08/2020 (First Available Due Date); 09/09/2020 (Expiration Date)
COVID-19	Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	NIH	08/07/2020; 09/09/2020 (Expiration)
COVID-19	Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations	NIH	07/08/2020 (First Available Due Date); 09/09/2020 (Expiration)
COVID-19	Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	NIH; Office of The Director, National Institutes of Health (OD)	07/08/2020 (First Available Due Date); 08/07/2020; 09/09/2020 (Expiration)
COVID-19 FOUNDATION FUNDING CYSTIC FIBROSIS	SARS-CoV-2 and Cystic Fibrosis Research Award	https://www.cff.org	07/17/2020 (Letter of Intent); 10/01/2020 (Full Application)
COVID-19 NIH DIRECTOR’S AWARDS PROGRAM	NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional)	Office of Strategic Coordination (Common Fund)	09/30/2020; 10/01/2020 (Expiration)
COVID-19	Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)	National Heart, Lung, and Blood Institute	03/17/2020 (First Available Due Date); 10/06/2020 (Expiration)
COVID-19	Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)	National Center for Advancing Translational Sciences	06/05/2020 (Frist Available Due Date); 10/17/2020 (Expiration)
COVID-19	NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)	National Institute on Aging	07/01/2020; 08/03/2020; 09/01/2020; 10/01/2020; 11/02/2020; 12/01/20220; 01/04/2021; 02/01/2021; 02/02/2021 (Expiration)
COVID-19	Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)	National Institute of Biomedical Imaging and Bioengineering	04/02/2020 (First Available Due Date); 11/10/2020 (Expiration Date)
COVID-19 TRANSLATIONAL	Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs	National Center for Advancing Translational Sciences	05/04/2020 (First Available Due Date); 11/11/2020 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need	National Center for Advancing Translational Sciences	06/12/2020 (First Available Due Date); 11/11/2020 (Expiration Date)
COVID-19 HEALTHCARE DISPARITIES	Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)	National Institute on Minority Health and Health Disparities; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Eye Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Nursing Research; Office of Disease Prevention; Office of Research on Women's Health	08/28/2020; 12/01/2020; 12/02/2020 (Expiration)
COVID-19	Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)	NIH	08/28/2020; 12/01/2020; 12/02/2020 (Expiration)
COVID-19 HEALTHCARE DISPARITIES	Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)	NIH	08/28/2020; 12/01/2020; 12/02/2020 (Expiration)
COVID-19 HEALTHCARE DISPARITIES	Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations	NIH	On a rolling basis through 12/15/2020; 12/16/2020 (Expiration); 06/10/2020 (First Available Due Date); 12/30/2020 (Expiration Date)
COVID-19	Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)	National Institute of Diabetes and Digestive and Kidney Diseases	12/16/2020; 12/17/2020 (Expiration)
COVID-19	Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19	National Institute of Mental Health; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Eye Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Minority Health and Health Disparities; National Institute of Nursing Research; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health	06/10/2020 (First Available Due Date); 12/30/2020 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations	National Institute on Minority Health and Health Disparities; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Eye Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of Mental Health; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health	06/10/2020 (First Available Due Date); 12/30/2020 (Expiration Date)
COVID-19	Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic	National Institutes of Health (NIH); Agency for Healthcare Research and Quality (AHRQ ); The National Institute for Occupational Safety and Health ( NIOSH)	For applications submitted for the January 2021 council (beginning with applications submitted for the May 25, 2020 due date for Fall 2020 review meetings), the NIH, AHRQ, and NIOSH will accept a one-page update with preliminary data as post-submission materials for applications submitted under all activity codes, ONLY if the Funding Opportunity Announcement (FOA) used for submission allowed preliminary data in the application. One page of preliminary data will be accepted for single component applications or for each component of a multi-component application.; The deadline for submitting all post-submission materials, including preliminary data, will be 30 days before the study section meeting. Because applications for emergency competitive revisions and urgent competitive revisions undergo expedited review, post-submission materials will not be accepted for those applications.; All other materials listed in NOT-OD-19-083 as acceptable post-submission materials will continue to be accepted if submitted 30 days before the study section meeting.
COVID-19	Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2	National Institute of General Medical Sciences (NIGMS)	03/25/2020 (First Available Due Date); 02/06/2021 (Expiration Date)
COVID-19	Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)	National Institute of Mental Health; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Eye Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute on Minority Health and Health Disparities; National Institute of Nursing Research; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health	08/20/2020; 12/02/2020; 03/02/2021; 03/03/2021 (Expiration)
COVID-19 DIGITAL HEALTHCARE	Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)	NIH	08/20/2020; 12/02/2020; 03/02/2021; 03/03/2021 (Expiration)
COVID-19 SOCIAL CONNECTEDNESS AND ISOLATION	[1] Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery [R01, Clinical Trials Not Allowed, CTNA, PAR-19-373] [2] Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery[R01, Basic experimental studies with humans required, BESH, PAR-19-384]	NIH	03/17/2021; 03/18/2021 (Expiration)
COVID-19	Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)	National Institute of Allergy and Infectious Diseases (NIAID)	03/25/2020 (First Available Due Date); 03/25/2021 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)	National Institute of Biomedical Imaging and Bioengineering	04/05/2020 (First Available Due Date); 03/31/2021 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus	National Institute on Drug Abuse	03/19/2020 (First Available Due Date); 03/31/2021 (Expiration)
COVID-19 NOTICE OF SPECIAL INTEREST	NIDA Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus	NIH; National Institute on Drug Abuse (NIDA)	03/19/2020 (First available due date); 03/31/2021 (Expiration)
COVID-19	NIDA Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus	NIH; National Institute on Drug Abuse (NIDA)	03/19/2020 (First available due date); 03/31/2021 (Expiration)
COVID-19 BEHAVIORAL SCIENCES SOCIAL SCIENCES	Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences	Office of Behavioral and Social Sciences Research (OBSSR); National Heart, Lung, and Blood Institute (NHLBI); National Institute on Aging (NIA); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Environmental Health Sciences (NIEHS); National Center for Complementary and Integrative Health (NCCIH); National Cancer Institute (NCI)	04/13/2020 (First Available Due Date); 04/01/2021 (Expiration)
COVID-19	Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)	National Institute of Allergy and Infectious Diseases	04/05/2020 (First Available Due Date); 04/05/2021 (Expiration)
COVID-19	Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System	National Institute of Neurological Disorders and Stroke	05/01/2020 (First Available Due Date); 04/15/2021 (Expiration Date)
COVID-19	Notice of Change to Eligible Activity Codes for NOT-NS-20-051 "Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System"	National Institute of Neurological Disorders and Stroke	05/01/2020 (First Available Due Date); 04/15/2021 (Expiration Date)
COVID-19	Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency caused by Coronavirus Disease 2019 (COVID-19)	National Institute of Mental Health	03/27/2020 (First Available Due Date); 04/16/2021 (Expiration Date) NOT-MH-20-047; 04/06/2020 (First Available Due Date); 05/01/2021 (Expiration Date) NOT-AG-20-022 05/01/2020 (First Available Due Date); 05/01/2021 (Expiration Date) NOT-MD-20-019
COVID-19	Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus NOT-MH-20-047	National Institute of Mental Health; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute on Minority Health and Health Disparities; Office of Disease Prevention	03/27/2020 (First Available Due Date); 04/16/2021 (Expiration Date)
COVID-19	Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA	National Institute on Alcohol Abuse and Alcoholism	05/15/2020 (First Available Due Date); 04/16/2021 (Expiration Date)
COVID-19	Frequently Asked Questions for NOT-AG-20-022 Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)	National Institute on Aging	04/06/2020 (First Available Due Date); 05/01/2021 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)	National Institute on Aging (NIA); National Institute of Mental Health (NIMH)	04/06/2020 (First Available Due Date); 05/01/2021 (Expiration)
COVID-19 HEALTHCARE DISPARITIES	Notice of Information for Date of Submission to NOT-MD-20-019 and NIMHD Consideration for FY Award	National Institute on Minority Health and Health Disparities	05/01/2020 (First Available Due Date); 05/01/2021 (Expiration); applicants who apply before 07/15/2020 will be considered for funding during FY 2020); applicants who apply after 07/15/2020 will be considered for FY 2021 [for NOT-MD-20-019]
COVID-19	Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities NOT-MD-20-019	National Institute on Minority Health and Health Disparities; National Institute on Aging; National Institute of Mental Health	05/01/2020 (First Available Due Date); 05/01/2021 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)	National Institute of Environmental Health Sciences	05/01/2020 (First Available Due Date); 05/04/2021 (Expiration)
COVID-19	Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on COVID-19	National Institute of Environmental Health Sciences (NIEHS)	05/01/2020 (First Available Due Date); 05/04/2021 (Expiration Date)
COVID-19	[1] Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) [2] Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)	National Institute of Environmental Health Sciences (NIEHS) [NOT-ES-20-015]	05/01/2020 (First Available Due Date) 05/04/2021 (Expiration Date); [NOT-ES-20-015]; 07/22/2020 (First Estimated Application Due Date) [NOT-MD-20-023]
COVID-19	Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)	National Institute of Allergy and Infectious Diseases	07/02/2020 (First Available Due Date); 07/02/2021 (Expiration Date) [for NOT-AI-20-059]
COVID-19	Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)	National Institute of Allergy and Infectious Diseases	07/02/2020 (First Available Due Date); 07/02/2021 (Expiration Date)
COVID-19	Notice of Change in Eligibility and Activity Codes for NOT-TR-20-011, Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need	National Center for Advancing Translational Sciences	05/04/2020 (First Available Due Date); 07/10/2021 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI) Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need	National Center for Advancing Translational Sciences (NCATS)	05/04/2020 (First Available Due Date); 07/10/2021 (Expiration)
COVID-19 DOWN SYNDROME	Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project	National Institutes of Health; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Cancer Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute on Minority Health and Health Disparities; National Institute of Neurological Disorders and Stroke; Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs	07/13/2020 (First Available Due Date); 07/13/2021 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)	National Institute of Allergy and Infectious Diseases	06/16/2020 (First Available Due Date); 09/08/2021 (Expiration Date)
COVID-19 SUBSTANCE USE DISORDERS	Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)	National Institute on Drug Abuse; National Cancer Institute	06/08/2020; 10/06/2020; 02/08/2021; 06/08/2021; 10/08/2021; 10/09/2021 (Expiration)
COVID-19	Notice of National Cancer Institute (NCI) Participation in PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)	National Cancer Institute (NCI)	04/03/2020 (Release Date); 01/25/2022 (Expiration) ; Earliest start dates may vary by awarding IC. See the Urgent Guide Notices for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
COVID-19	Notice of NIDCD's Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"	National Institute on Deafness and Other Communication Disorders (NIDCD)	04/02/2020 (Release Date): 01/25/2022 (Expiration) ; Earliest start dates may vary by awarding IC. See the Urgent Guide Notices for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
COVID-19	Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus	National Center for Advancing Translational Sciences	05/15/2020 (First Available Due Date); 01/26/2022 (Expiration)
COVID-19	Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus	National Center for Advancing Translational Sciences	05/15/2020 (First Available Due Date); 01/26/2022 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21)	National Library of Medicine	06/16/2020 (First Available Due Date); 06/17/2022 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders	National Institute on Deafness and Other Communication Disorders	10/05/2020 (First Available Due Date); 09/08/2022 (Expiration Date)
COVID-19	Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials	National Heart, Lung, and Blood Institute	05/01/2020 (First Available Due Date); 10/06/2022 (Expiration Date)
COVID-19	Notice of NIDCD's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"	National Institute on Deafness and Other Communication Disorders	03/10/2023 (Expiration) [PA-20-135]
COVID-19	Notice of NIDA Participation in PA-20-135, "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"	National Institute on Drug Abuse	03/10/2023 (Expiration) [PA-20-135]
COVID-19	Notice of ORWH Participation in PA-20-135, Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement Clinical Trial Optional)	Office of Research on Women's Health	03/10/2023 (Expiration) [PA-20-135]
COVID-19 OPPORTUNITIES CURATED IN PIVOT	Resources to access COVID-19 Funding Opportunities and New Website: [1] Coronavirus Funding Opportunities Curated by SPA in PIVOT [this regularly updated link may require PIVOT registration (see below for instructions)] [2] Pivot is a Funding Opportunity Database, as a one-stop shop to identify COVID-19 opportunities from federal, private, and global sponsors [3] Pivot Instructions [4] COVID-19: FAQs and Resources Relating to Research [Columbia Research and SPA] [5] COVID-19 Research Opportunities and other resources to support researchers [6] COVID-19 Research Funding Opportunities Curated by SPA and Research at Columbia	Columbia Research https://research.columbia.edu ; SPA https://spa.columbia.edu/ [brought to our attention by] Stephanie Scott [Director of Policy and Research Development] Columbia \| Research; Sponsored Projects Administration; sfs2110@cumc.columbia.edu ; Website: https://spa.columbia.edu/	Please note that effective May 01, 2020 (05/01/2020) SPA will continue to support the funding opportunity database Pivot, and will no longer support InfoEd SPIN / SMARTS
COVID-19 RESEARCH AT COLUMBIA UPDATED FAQS AND LINKS	Research at Columbia, updated Covid-19 focused FAQS and Links [1] COVID-19 SPA Town Hall 05/08/2020 (Slides) [2] COVID-19 Research FAQs [3] Sponsored Projects Town Halls [4] What you should know about your Sponsored Projects: A Summary of the SPA COVID Town Hall 5/8/2020	Research @ Columbia and Sponsored Projects Administration	NA
CRIMINAL JUSTICE SYSTEM	Research and Evaluation in Safety, Health, and Wellness in the Criminal Justice System, Fiscal Year 2020	National Institute of Justice/Department of Justice	04/29/2020
DEDICATED CU WEBSITE, COVID-19: FAQS AND RESOURCES RELATING TO RESEARCH	Dedicated CU Website COVID-19: FAQs and Resources Relating to Research	https://research.columbia.edu	NA
NEW DEDICATED CU WEBSITE, COVID-19: FAQS AND RESOURCES RELATING TO RESEARCH	New Dedicated CU Website COVID-19: FAQs and Resources Relating to Research Dear Mailman Investigators, I want to remind everyone of the following site at Columbia that aggregates all of the COVID-19 related research news. This site is being updated on a regular basis. https://research.columbia.edu/COVID-19_Research If you have any unanswered questions please feel free to reach out to Pam or me. Gary Gary W. Miller, Ph.D. Vice Dean for Research Strategy and Innovation Professor, Department of Environmental Health Sciences Columbia University Mailman School of Public Health 722 West 168th Street, Room 1411B, New York, NY 10032 gm2815@cumc.columbia.edu	https://research.columbia.edu	NA
NIH ANNOUNCEMENTS COVID-19	General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19	NIH; Office of The Director, National Institutes of Health (OD)	03/10/2020 (Release Date)
RESEARCH RESOURCES COVID-19 TRANSMISSION, 03/23/2020	Research Resources Covid-19 Transmission, 03/23/2020	Research Resources	Transmission Date 03/23/2020
SPA COVID TOWN HALL SUMMARY	What you should know about your Sponsored Projects: A Summary of the SPA COVID Town Hall 5/8/2020	Sponsored Projects Administration	05/08/2020 (Event Date)

Resources to access COVID-19 Funding Opportunities and New Website:

The NIH has created an COVID-19 Literature: The COVID-19 Portfolio Tool

Coronavirus Funding Opportunities Curated by SPA in PIVOT [this regularly updated link may require PIVOT registration (see below for instructions)]

Pivot is a Funding Opportunity Database, as a one-stop shop to identify COVID-19 opportunities from federal, private, and global sponsors

Pivot Instructions

COVID-19: FAQs and Resources Relating to Research [Columbia Research and SPA]

COVID-19 Research Opportunities and other resources to support researchers

New Dedicated CU Website COVID-19: FAQs and Resources Relating to Research

COVID-19 Research Opportunities and other resources to support researchers

Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients

COVID-19 FAQ Updates and Pay Continuation on Sponsored Projects

Update: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)

NIDA has issued a Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus

Dr. Anil Rustgi, director of the Herbert Irving Comprehensive Cancer Center, would like to widely publicize their new COVID-19 research pilot funding opportunity with Mailman Faculty: The Herbert Irving Comprehensive Cancer Center (HICCC) is seeking applications for research projects focused on SARS-CoV-2 (COVID-19), due 04/17/2020

Health and Policy Management Live and Recorded Virtual Events (April 13, 14, 17, as of this posting)

Columbia Research has activated a new dedicated CU Website COVID-19: FAQs and Resources Relating to Research

Research Resources Covid-19 Transmission, 03/23/2020

Dear Mailman School Faculty,

Please see below time sensitive Covid-19 Research Resources focused information, forwarded to our attention by Sponsored Projecrts Administration. Further updates will be sent via the Friday newsletter unless they are of time urgency, so please watch for the updates on Friday.

NIH announcements and funding opportunities on COVID-19

NIH has created one website to house all important announcements and funding opportunities related to COVID-19, which can be found at Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding. You may wish to bookmark this page, and it is also accessible from our COVID-19 (Novel Coronavirus): Frequently Asked Questions Relating to Research webpage, which is updated daily. The funding opportunities can also be found on our webpage at Where can I find funding opportunities related to COVID-19?

Highlighted below are the announcements that have been issued. The Offices of the EVPR will issue further guidance with regards to flexibilities available to applicants and recipients as we further assess the expectations of NIH and other federal sponsors. Please stay tuned for more information.

In the interim, if you have a project-specific question, you can reach out to your SPA Project Officer. You can also send questions to COVID19_research@columbia.edu.

NIH Announcements and Guidance:

Proposal Submission & Award Management

NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) - NOT-OD-20-082

General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19 - NOT-OD-20-083

Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 - NOT-OD-20-086

Human Subjects & Clinical Trials

Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 - NOT-OD-20-087

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic

Animal Welfare

OLAW Webinar: Pandemic Contingency Planning and Its Impact on Animal Care March 19, 2020

Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19 - NOT-OD-20-088

Peer Review

Based on NIH Guidance on Travel and Meetings, in-person NIH peer review meetings are being held in alternate formats. Scientific review officers will be in contact with peer reviewers about these changes.

FAQs

NIH FAQs: COVID-19 Flexibilities for Applicants and Recipients

PIVOT

PIVOT, a tool which allows instantaneous access to the funding opportunities that are right for you

Coronavirus Funding Opportunities Curated by SPA in PIVOT

Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients

COVID-19 FAQ Updates and Pay Continuation on Sponsored Projects

Update: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)

Update on Covid-19 Flexibilities for the Research Community; Mike Lauer, NIH Deputy Director for Extramural Research; Video_03.26.2020

A Message from the Vice Dean for Research Strategy and Innovation, archived preamble to R2eport 03/20/2020

NIDA has issued a Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus

Council on Governmental Relations compiled FAQs relative to Covid-19

Columbia Research has posted and will update as new information is received COVID-19 (Novel Coronavirus): Frequently Asked Questions Relating to Research

NIH has released (03/10/2020) FAQs to address general questions associated with proposal submission and award management that may arise in relation to COVID-19

Research Resources Covid-19 Transmission 03/23/2020 Archived

Research Resources Covid-19 Transmission 03/18/2020 Archived

CUIMC Research Administration will conduct a Virtual (Zoom) Forum, April 1, 2020 10 AM – 12 Noon

The Herbert Irving Comprehensive Cancer Center (HICCC) is seeking applications for research projects focused on SARS-CoV-2 (COVID-19), due 04/17/2020

Office of Management and Budget Memo on Grants and Contracts 03.19.2020; Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations

Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients

NIH has released (03/10/2020) FAQs to address general questions associated with proposal submission and award management that may arise in relation to COVID-19

COVID-19 Research

Covid-19 focused opportunities and announcements, R2eport Archival New This Week (NTW) Tabular 07/31/2020 – 12/20/2019

Category (first appearance)

Title (linked)

Sponsor

Deadline (if multiple, first and last presented)

COVID 19

NIH ANNOUNCEMENTS

NIH

04/13/2020 (Release Date)

COVID-19

Agency for Healthcare Research and Quality (AHRQ)

NA

COVID-19

Columbia University Herbert Irving Comprehensive Cancer Center; https://cancer.columbia.edu/

NA, please see individual funding opportunities

COVID-19

Eunice Kennedy Shriver National Institute of Child Health and Human Development

COVID-19

Eunice Kennedy Shriver National Institute of Child Health and Human Development

COVID-19

Eunice Kennedy Shriver National Institute of Child Health and Human Development

COVID-19

Eunice Kennedy Shriver National Institute of Child Health and Human Development

COVID-19

Eunice Kennedy Shriver National Institute of Child Health and Human Development

COVID-19

Eunice Kennedy Shriver National Institute of Child Health and Human Development

COVID-19

FOUNDATION FUNDING

MATERNAL AND CHILD HEALTH

Ferring Pharmaceuticals

Ferring COVID-19 Investigational Grants will be awarded within 14 days of receipt from 15th April – 31st October 2020.; 10/31/2020

COVID-19

FOUNDATION FUNDING

Open

COVID-19

HIGH PERFORMANCE COMPUTING

SRCPAC Major players offering Access to High Performance Computing for COVID-19 Research

[1] Covid-19 High Performance Computing HPC Consortium

[2] Covid-19 HPC High Performance Computing Webinar Presentation

[3] All Active Projects, Covid-19 HPC High Performance Computing Consortium

[4] Proposal Submission Website, Covid-19 HPC High Performance Computing Consortium

https://covid19-hpc-consortium.org/; [Covid-19 High Performance Computing HPC Consortium]

Please see all active projects

COVID-19

NA; This webpage will continue to be updated frequently as new information is received.

COVID-19

BIG DATA

Ongoing

COVID-19

NA

COVID-19

WITHDRAWN DUE TO COVID-19 PANDEMIC

Due to the Covid-19 pandemic, the 2020 Translational grant (adult cancer types) Request For Applications (RFA), has been withdrawn, effective immediately

COVID-19

WEEKLY HIGHLIGHT

RETURNING TO CAMPUS

[1] Mailman School; Returning to Campus

[2] Mailman School; Returning to Campus update 07/22/2020

[3] Mailman School; Returning to Campus update 07/30/2020

[4] Mailman School; Returning to Campus; Survey re MSPH IRB Approved Project Resumption, please complete by COB 08/02/2020

[5] Mailman School; Returning to Campus; IRB Focused Town Hall 07/29/2020 Archived AV

Mailman School

NA; page updated regularly

COVID-19

LATE APPLICATION POLICY

National Cancer Institute

Cancer research education (R25) grant applications submitted to NCI's Funding Opportunity Announcements PAR-18-476, PAR-18-477, and PAR-18-478 for the application due date of May 25, 2020, will be accepted for consideration if complete and received by 5:00 PM local time June 30, 2020

COVID-19

National Center for Advancing Translational Sciences

See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; ; 03/10/2023 (Expiration)

COVID-19

National Center for Advancing Translational Sciences (NCATS)

COVID-19

National Center for Complementary and Integrative Health; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism

Ferring COVID-19 Investigational Grants will be awarded within 14 days of receipt from 15^th April – 31^st October 2020.; 10/31/2020